Call Number (LC) Title Results
HD9665.5 .S45 2015 Selling sickness / 2
HD9665.5 .S56 Thalidomide and the power of the drug companies / 1
HD9665.5 .S57 2018eb Ghost-managed medicine Big Pharma's invisible hands / 1
HD9665.5 .S578 2013 Lean biomanufacturing : creating value through innovative bioprocessing approaches / 2
HD9665.5 .S58 2016 The future of pharma : evolutionary threats and opportunities / 1
HD9665.5 .S59 1991 Pharmaceutical marketing : strategy and cases / 1
HD9665.5 .S6 Principles of pharmaceutical marketing / 1
HD9665.5 .S6 1975 Principles of pharmaceutical marketing / 1
HD9665.5 .S64 1990 Inside the drug industry / 2
HD9665.5 S658 2016 The Future of Pharma : Evolutionary Threats and Opportunities. 1
HD9665.5 .S68 1989 Multinational drug companies : issues in drug discovery and development / 2
HD9665.5 .S776 1996 Studies in pharmaceutical economics / 1
HD9665.5 .S79 2011eb Venturing into the bioeconomy professions, innovation, identity / 1
HD9665.5 .T34 1993 The world pharmaceutical industry / 1
HD9665.5 .T46 2016eb Therapeutic revolutions : pharmaceuticals and social change in the twentieth century / 1
HD9665.5 .T765 2016eb Ema e le relazioni con le big pharma. 1
HD9665.5 .T83 1984 The world health market : the future of the pharmaceutical industry / 2
HD9665.5 .T9683 2002eb The 2000-2005 world outlook for OTC healthcare products. 1
HD9665.5 T97 2002eb The 2000-2005 world outlook for prescription. 1
HD9665.5 .U33 2012eb How to commercialise research in biotechnology? effectiveness of the innovation process and of technology transfer in the biotechnology sector / 1